Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis

18 Jul 2016

Abstract excerpt

BACKGROUND: Formyl peptide receptor 1 (FPR1) is a G protein-coupled receptor mainly expressed by the cells of myeloid origin, where it mediates the innate immune response to bacterial formylated peptides. High expression of FPR1 has been detected in various cancers but the function of FPR1 in tumorigenesis is poorly understood. METHODS: Expression of FPR1 in neuroblastoma cell lines and primary tumors was studied...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Response and Inflammation
Share to Pregnancy-related medical research
Share to S100 Proteins and Annexins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27432059
DOI: 10.1186/s12885-016-2545-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesisPMID 27432059Read ↗

The Expression of Formyl Peptide Receptor 1 is Correlated with Tumor Invasion of Human Colorectal CancerSemantic proximity Read ↗

Cannabinol Inhibits Cellular Proliferation, Invasion, and Angiogenesis of Neuroblastoma via Novel miR-34a/tRiMetF31/PFKFB3 AxisSemantic proximity Read ↗

An Insight into GPCR and G-Proteins as Cancer DriversSemantic proximity Read ↗

Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability <i>in vitro</i> and impairs tumor growth <i>in vivo</i>Semantic proximity Read ↗

Didymin: an orally active citrus flavonoid for targeting neuroblastomaSemantic proximity Read ↗

Targeting tachykinin receptors in neuroblastomaSemantic proximity Read ↗

Comparative analysis of Formyl peptide receptor 1 and Formyl peptide receptor 2 reveals shared and preserved signaling profilesSemantic proximity Read ↗

The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.Semantic proximity Read ↗

NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth.Semantic proximity Read ↗

Quantitative Phosphoproteomic Analysis Identifies Activation of the RET and IGF-1R/IR Signaling Pathways in NeuroblastomaSemantic proximity Read ↗

Analysis of a missense variant of the human N-formyl peptide receptor that is associated with agonist-independent beta-arrestin association and indices of inflammation.Semantic proximity Read ↗

G protein-coupled receptors as promising cancer targets.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.